-
UK prepares five million vaccine doses in case of bird flu pandemic | UK News
admin
More than five million doses of a vaccine are being prepared in the UK to combat any potential bird flu pandemic. The jab – the human H5 influenza vaccine – is only intended for use if a strand of the virus known as H5N1 spreads among humans. There is no evidence at this stage of…
-
British volunteers sought for trial of vaccine to protect against norovirus | UK News
admin
Volunteers are being sought to help trial a new vaccine against norovirus, or the winter vomiting bug, after initial results showed the jab created a “strong immune response”. The illness is the most common infectious cause of vomiting and diarrhoea and spreads easily through contact with contaminated surfaces or someone else who has it. Every…
-
World’s first ovarian cancer vaccine being developed in UK ‘could wipe out the disease’ | UK News
admin
The world’s first ovarian cancer vaccine could wipe the disease out, researchers have said. OvarianVax is a vaccine that teaches the immune system to recognise and attack the earliest stages of ovarian cancer. It’s being developed by scientists at the University of Oxford. The hope is that women could receive the jab preventatively on the…
-
Lung cancer patient is first in UK to receive experimental vaccine | UK News
admin
A lung cancer patient has become the first in the UK to receive a new experimental vaccine to help his body fight the disease. Janusz Racz, 67, had six syringes of the jab, each containing genetic material for a different part of the tumour, to train five billion cells in his immune system to go…
-
delay, dementia, herpes, News, NHS, onset, Science, shingles, significantly, study, suggests, targeting, Tech, vaccine, virus, zoster
NHS shingles vaccine targeting herpes zoster virus could significantly delay onset of dementia, study suggests | Science & Tech News
admin
A vaccine being used by the NHS to prevent shingles could also significantly delay the onset of dementia, according to new research that has left scientists baffled. The study on more than 200,000 older people shows those who were given the ‘recombinant’ vaccine Shingrix were diagnosed with dementia an average of 164 days later than…
-
Pregnant women urged to get whooping cough vaccine as nine young babies die amid surge in cases in England | UK News
admin
Pregnant women have been advised to get vaccinated against whooping cough after nine young babies died as cases of the illness surged in England. Whooping cough, which affects the lungs and breathing tubes and spreads very easily, according to the NHS, is responsible for the deaths of nine babies between November and the end of…
-
Personalised cancer vaccine is a ‘landmark moment’, as thousands set to trial it | UK News
admin
A personalised cancer vaccine jab that could help prevent the illness returning after surgery, has been given to a patient for the first time in what’s been called a “landmark moment” for people who have the disease. Elliot Pfebve, a bowel cancer patient, was referred to the Queen Elizabeth Hospital Birmingham for chemotherapy and to…
-
AstraZeneca starts worldwide withdrawal of COVID vaccine | Science & Tech News
admin
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine – ending an era in which it saved millions of lives while being dogged by controversy. The jab, developed at Oxford University, was once hailed as “the vaccine for the world” because it could be stored in fridges rather than the ultra-cold freezer temperatures originally…
-
Dad who suffered brain injury days after getting COVID vaccine sues AstraZeneca | UK News
admin
A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known of the risk of rare but serious side effects. Jamie Scott, who has two young boys and is now unable to work, is suing AstraZeneca…
-
RSV vaccine could cut baby hospital admissions by more than 80%, study suggests | Science & Tech News
admin
A vaccine to combat a common seasonal virus among babies could reduce hospital admissions by more than 80%, a trial has shown. Respiratory syncytial virus (RSV) impacts 90% of children before they reach the age of two, often causing a mild cold-like illness. But infection can also lead to severe lung problems like pneumonia, and…